A randomized controlled trial of continuous upper trunk brachial plexus block with different concentrations of ropivacaine for postoperative analgesia undergoing proximal humerus fractures

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000035340

Enrollment

Unknown

Registered

2020-08-08

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain for proximal humerus fractures

Interventions

H group:0.15% ropivacaine

M group:0.125% ropivacaine

L group: 0.10% ropivacaine

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Aged from 20 to 80 years, men and women there is no limit, in 50-80 kg, able to communicate effectively, ASA I~ III level.

Exclusion criteria

Exclusion criteria: With nervous system disorders, blood coagulation dysfunction, history of allergies to local anesthetics, history of diabetes, there is any breakage and infection lesions, or refused to regional nerve block anesthesia.

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale;Bromage;	—

Countries

China

Contacts

Public ContactLu Zhiqiang

The Second Affiliated Hospital of Nanjing Medical University

njeyzhiqiang@163.com+86 18951762774

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026